Danielle Cook
Physician Assistant · Petoskey, MINPI 1073152641
Payments from drug & device makers
Across 397 payments — averaging $21.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$912
- Inspire Medical Systems, Inc.$664
- Regeneron Healthcare Solutions, Inc.$562
- Jazz Pharmaceuticals Inc.$540
- Sanofi$504
- plus $4K from 34 others
What the payments were for
- Food & beverage$7,88593%
- Education$5717%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,456 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 24 | $313,731 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 209 | $190,939 |
| Dupixent PenDupilumab | 18 | $90,168 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 76 | $72,836 |
| Spiriva RespimatTiotropium Bromide | 39 | $25,141 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 34 | $20,885 |
| Breo ElliptaFluticasone/Vilanterol | 32 | $15,435 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 24 | $15,216 |
| Spiriva HandihalerTiotropium Bromide | 20 | $14,402 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 48 | $11,194 |
| SymbicortBudesonide/Formoterol Fumarate | 33 | $7,972 |
| Advair HfaFluticasone Propion/Salmeterol | 15 | $7,184 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 170 | $5,575 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 11 | $4,479 |
| Arnuity ElliptaFluticasone Furoate | 19 | $4,199 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat | $394 | $359,75697 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta | $912 | $225,789284 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,515 | $85,287120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Petoskey
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
- Patrick CooneyNew Baltimore$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.